REQUEST A DEMO
Total
USD $0.00
Search more companies

Impact Therapeutics Inc. (南京英派药业股份有限公司) (China)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Impact Therapeutics Inc. Profile Updated: August 24, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Chinese Download a sample report

Impact Therapeutics Inc. (南京英派药业股份有限公司) is a company in China, with a head office in Shanghai. The enterprise currently operates in the Pharmaceutical Preparation Manufacturing sector. The enterprise was incorporated on August 26, 2026. The company’s latest financial report indicates a net sales revenue increase of 14.02% in 2025. During that time, Impact Therapeutics Inc. (南京英派药业股份有限公司)’s total assets decreased by 13.98%. In 2025, Impact Therapeutics Inc. (南京英派药业股份有限公司)’s net profit margin decreased by 14.24%.

Headquarters
27Th Floor, New Bund Times Square, 399 West Haiyang Road, Pudong New District
Shanghai; Shanghai;

Contact Details: Purchase the Impact Therapeutics Inc. (南京英派药业股份有限公司) report to view the information.

Website: http://www.impacttherapeutics.com

Basic Information
Outstanding Shares:
Purchase the Impact Therapeutics Inc. (南京英派药业股份有限公司) report to view the information.
Financial Auditors:
Purchase the Impact Therapeutics Inc. (南京英派药业股份有限公司) report to view the information.
Incorporation Date:
August 26, 2026
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Subsidiaries
Impact Pharmaceutical (Yangzhou) Co., Ltd.
100%
Impact Therapeutics (Shanghai), Inc.
100%
Impact Therapeutics Australia Pty Ltd (Australia)
100%
Company Performance
Financial values in the chart are available after Impact Therapeutics Inc. (南京英派药业股份有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
14.02%
Total Operating Revenue
14.54%
Operating Profit
-11.15%
EBITDA
-12.68%
Net Profit/Loss for the Period
-16.16%
Total Assets
-13.98%
Total Equity
-28.7%
Operating Profit Margin
15.82%
Net Profit Margin
-14.24%
Return on Equity (ROE)
-3.34%
Debt / Equity
0.34%
Quick Ratio
-1.31%
Cash Ratio
-0.1%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?